Publication | Open Access
Ketamine for the treatment of acute pain
14
Citations
2
References
2021
Year
Acute PainPain MedicineAnesthetic MechanismPharmacotherapyExperimental PharmacologyPharmacodynamic ModelingMolecular PharmacologyAnesthesiaPsychomimetic EffectsPain ManagementAnalgesicsAnesthetic PharmacologyHealth SciencesPostoperative Pain ManagementNeuropharmacologyPharmacologyDissociative AnesthesiaAnaesthetic AgentPain ResearchLow DosesDrug TherapyDissociative PharmacologyMedicineTrauma PainDrug DiscoveryAnesthesiology
Ketamine is a phencyclidine (PCP) derivative that exerts its effects primarily through N -methyl-d-aspartate receptor inhibition.[1][1] At low doses (0.1–0.3 mg/kg), ketamine produces mainly analgesia. Dissociative anesthesia and psychomimetic effects occur with higher doses (≥ 1.0 mg/kg). Low-
| Year | Citations | |
|---|---|---|
Page 1
Page 1